A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection

Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 291; no. 41; pp. 21596 - 21606
Main Authors Vrentas, Catherine E., Moayeri, Mahtab, Keefer, Andrea B., Greaney, Allison J., Tremblay, Jacqueline, O'Mard, Danielle, Leppla, Stephen H., Shoemaker, Charles B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.10.2016
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LFN, EFN) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.
AbstractList Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LF , EF ) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.
Infection with Bacillus anthracis , the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo , with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LF N , EF N ) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.
Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LFN, EFN) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.
Author Vrentas, Catherine E.
Keefer, Andrea B.
Leppla, Stephen H.
Moayeri, Mahtab
O'Mard, Danielle
Tremblay, Jacqueline
Shoemaker, Charles B.
Greaney, Allison J.
Author_xml – sequence: 1
  givenname: Catherine E.
  surname: Vrentas
  fullname: Vrentas, Catherine E.
  organization: From the Department of Biology, Frostburg State University, Frostburg, Maryland 50010
– sequence: 2
  givenname: Mahtab
  surname: Moayeri
  fullname: Moayeri, Mahtab
  organization: Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and
– sequence: 3
  givenname: Andrea B.
  surname: Keefer
  fullname: Keefer, Andrea B.
  organization: Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and
– sequence: 4
  givenname: Allison J.
  surname: Greaney
  fullname: Greaney, Allison J.
  organization: Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and
– sequence: 5
  givenname: Jacqueline
  surname: Tremblay
  fullname: Tremblay, Jacqueline
  organization: Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Maryland 01536
– sequence: 6
  givenname: Danielle
  surname: O'Mard
  fullname: O'Mard, Danielle
  organization: Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and
– sequence: 7
  givenname: Stephen H.
  surname: Leppla
  fullname: Leppla, Stephen H.
  organization: Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and
– sequence: 8
  givenname: Charles B.
  surname: Shoemaker
  fullname: Shoemaker, Charles B.
  email: charles.shoemaker@tufts.edu
  organization: Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Maryland 01536
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27539858$$D View this record in MEDLINE/PubMed
BookMark eNp1kU9vEzEQxS1URP_AmRvysRw2tdfrrPeCFEJLKgWB1IC4WV57nLja2MF2ovL5-GI4pI3ggC-WZn7z3mjeOTrxwQNCrykZUdI2V_e9Hn2idDxqm46K5hk6o0SwinH6_QSdEVLTqqu5OEXnKd2T8gr2Ap3WLWed4OIM_ZrgD24HMQG-g4yDxXfOLweoTFgr5_HEZ9cH4yDhy2-zWXqL1bLUU8Z5BfvuKqoHvAgPhZ1DXqkBK2_wtYG1wjdK5xAT_hLDzpkiofB7lVzCNkQ8DUUlbnV2we99S8-lDWhnncaTJfiMFyuV98MZdE5H4yfTW2_hz_RL9NyqIcGrx_8Cfb25Xkxn1fzzx9vpZF7ppmG5akgvmKK2rXXPmFampsIo0o616HhrWiO0KceredsROraC1sp2wHveWGONBnaB3h10N9t-DaXic1SD3ES3VvGnDMrJfzvereQy7CQvJoKRInD5KBDDjy2kLNcuaRgG5SFsk6SCcc74mNGCXh1QHUNKEezRhhK5j16W6OU-enmIvky8-Xu7I_-UdQG6AwDlRjsHUSbtwGswLpZDShPcf8V_A-A4w0E
CitedBy_id crossref_primary_10_1016_j_celrep_2020_01_107
crossref_primary_10_1016_j_bbagen_2018_08_019
crossref_primary_10_1021_acs_biochem_9b00184
crossref_primary_10_1016_j_bbrc_2020_04_073
crossref_primary_10_3389_fimmu_2024_1334829
crossref_primary_10_3390_mi14020281
crossref_primary_10_1021_acs_jafc_4c02257
crossref_primary_10_1371_journal_ppat_1010713
crossref_primary_10_1016_j_jmb_2020_01_006
crossref_primary_10_3389_fcimb_2021_697876
crossref_primary_10_1016_j_cimid_2018_09_009
crossref_primary_10_1038_s41598_023_41092_7
crossref_primary_10_1016_j_ijbiomac_2018_03_034
crossref_primary_10_1016_j_pep_2023_106411
crossref_primary_10_3390_bios11120483
crossref_primary_10_1007_s40291_021_00533_7
crossref_primary_10_1016_j_vaccine_2022_08_052
crossref_primary_10_3390_toxins9030107
crossref_primary_10_3389_fmicb_2023_1110541
crossref_primary_10_1016_j_bcp_2023_115640
crossref_primary_10_1016_j_ymthe_2019_03_002
crossref_primary_10_1074_jbc_M117_802231
crossref_primary_10_1111_pim_12584
crossref_primary_10_3389_fimmu_2022_1014377
crossref_primary_10_3390_toxins12100611
Cites_doi 10.1038/nsmb.1923
10.1371/journal.pone.0029941
10.1016/j.chom.2010.10.004
10.1371/journal.pone.0017665
10.3389/fonc.2012.00159
10.1128/IAI.74.1.682-693.2006
10.1128/IAI.05314-11
10.1371/journal.pone.0065855
10.1128/IAI.73.10.6547-6551.2005
10.1371/journal.pone.0106422
10.1080/19420862.2016.1185581
10.2217/nnm.13.86
10.1006/prep.2000.1208
10.1146/annurev-biochem-063011-092449
10.1016/j.ijpara.2007.02.005
10.1074/jbc.M115.658070
10.1074/jbc.M113.519207
10.1016/j.toxicon.2010.07.003
10.1146/annurev-micro-091014-104523
10.2217/fmb.11.32
10.1038/n35101998
10.1038/labinvest.2014.82
10.1128/iai.56.7.1807-1813.1988
10.1128/AAC.00941-13
10.1128/CVI.00611-15
10.1074/jbc.M114.627943
10.1128/IAI.01033-13
10.1128/IAI.00200-09
10.3390/toxins3081004
ContentType Journal Article
Copyright 2016 © 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
2016 by The American Society for Biochemistry and Molecular Biology, Inc.
2016 by The American Society for Biochemistry and Molecular Biology, Inc. 2016 The American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: 2016 © 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
– notice: 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
– notice: 2016 by The American Society for Biochemistry and Molecular Biology, Inc. 2016 The American Society for Biochemistry and Molecular Biology, Inc.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1074/jbc.M116.749184
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate VHHs against Anthrax Lethal and Edema Factors
EISSN 1083-351X
EndPage 21606
ExternalDocumentID 10_1074_jbc_M116_749184
27539858
S0021925820358415
Genre Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U54 AI057159
– fundername: National Institutes of Health
  grantid: U54 AI057159
– fundername: National Institute of Allergy and Infectious Diseases
  grantid: Intramural Research Program
GroupedDBID ---
-DZ
-ET
-~X
.55
.GJ
0SF
186
18M
29J
2WC
34G
39C
3O-
4.4
41~
53G
5BI
5GY
5RE
5VS
6I.
6TJ
79B
85S
AAEDW
AAFTH
AAFWJ
AARDX
AAXUO
AAYJJ
AAYOK
ABDNZ
ABFSI
ABOCM
ABPPZ
ABRJW
ABTAH
ACGFO
ACNCT
ACSFO
ACYGS
ADBBV
ADIYS
ADNWM
AENEX
AEXQZ
AFDAS
AFFNX
AFMIJ
AFOSN
AFPKN
AHPSJ
AI.
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CJ0
CS3
DIK
DU5
E.L
E3Z
EBS
EJD
F20
F5P
FA8
FDB
FRP
GROUPED_DOAJ
GX1
HH5
HYE
IH2
J5H
KQ8
L7B
MVM
N9A
NHB
OHT
OK1
P-O
P0W
P2P
QZG
R.V
RHF
RHI
RNS
ROL
RPM
SJN
TBC
TN5
TR2
UHB
UKR
UPT
UQL
VH1
VQA
W8F
WH7
WHG
WOQ
X7M
XFK
XJT
XSW
Y6R
YQT
YSK
YWH
YYP
YZZ
ZA5
ZE2
ZGI
ZY4
~02
~KM
0R~
AALRI
ADVLN
AITUG
AKRWK
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c443t-40b83a1f72cb33cad218da076c8957d7d8cd0832579016f812af9e5b54fdfdce3
IEDL.DBID RPM
ISSN 0021-9258
IngestDate Tue Sep 17 21:27:22 EDT 2024
Fri Oct 25 01:04:01 EDT 2024
Thu Nov 21 20:57:49 EST 2024
Sat Sep 28 08:39:24 EDT 2024
Fri Feb 23 02:45:51 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 41
Keywords anthrax toxin
EF
antibody
toxin
phage display
VHH
VNA
LF
microbial pathogenesis
epitope mapping
Language English
License This is an open access article under the CC BY license.
2016 by The American Society for Biochemistry and Molecular Biology, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c443t-40b83a1f72cb33cad218da076c8957d7d8cd0832579016f812af9e5b54fdfdce3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1074/jbc.M116.749184
PMID 27539858
PQID 1835535631
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5076830
proquest_miscellaneous_1835535631
crossref_primary_10_1074_jbc_M116_749184
pubmed_primary_27539858
elsevier_sciencedirect_doi_10_1074_jbc_M116_749184
PublicationCentury 2000
PublicationDate 2016-10-07
PublicationDateYYYYMMDD 2016-10-07
PublicationDate_xml – month: 10
  year: 2016
  text: 2016-10-07
  day: 07
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 2016
Publisher Elsevier Inc
American Society for Biochemistry and Molecular Biology
Publisher_xml – name: Elsevier Inc
– name: American Society for Biochemistry and Molecular Biology
References Leysath, Chen, Moayeri, Crown, Fattah, Chen, Das, Purcell, Leppla (bib12) 2011; 79
Hassanzadeh-Ghassabeh, Devoogdt, De Pauw, Vincke, Muyldermans (bib5) 2013; 8
Muyldermans (bib4) 2013; 82
Kaliberov, Kaliberova, Buggio, Tremblay, Shoemaker, Curiel (bib20) 2014; 94
Vance, Tremblay, Mantis, Shoemaker (bib6) 2013; 288
Pomerantsev, Sitaraman, Galloway, Kivovich, Leppla (bib26) 2006; 74
Mukherjee, Tremblay, Leysath, Ofori, Baldwin, Feng, Bedenice, Webb, Wright, Smith, Tzipori, Shoemaker (bib7) 2012; 7
Mukherjee, Dmitriev, Debatis, Tremblay, Beamer, Kashentseva, Curiel, Shoemaker (bib15) 2014; 9
Herrera, Tremblay, Shoemaker, Mantis (bib9) 2015; 290
Thullier, Avril, Mathieu, Behrens, Pellequer, Pelat (bib11) 2013; 8
Pant, Marcotte, Hermans, Bezemer, Frenken, Johansen, Hammarström (bib18) 2011; 6
Chen, Moayeri, Crown, Emerson, Gorshkova, Schuck, Leppla, Purcell (bib28) 2009; 77
Moayeri, Crown, Jiao, Kim, Johnson, Leysath, Leppla (bib14) 2013; 57
Moayeri, Leppla, Vrentas, Pomerantsev, Liu (bib1) 2015; 69
Moayeri, Leysath, Tremblay, Vrentas, Crown, Leppla, Shoemaker (bib3) 2015; 290
Liu, Miller-Randolph, Crown, Moayeri, Sastalla, Okugawa, Leppla (bib13) 2010; 8
Pannifer, Wong, Schwarzenbacher, Renatus, Petosa, Bienkowska, Lacy, Collier, Park, Leppla, Hanna, Liddington (bib29) 2001; 414
Park, Leppla (bib25) 2000; 18
Lim, Kim, Oh, Lee, Kim, Kim, Kang, Hong, Inn (bib16) 2005; 73
Adams, Griffin, Compson, Jairaj, Baker, Ceska, West, Zaccheo, Dave, Lawson, Humphreys, Heywood (bib22) 2016
Chen, Moayeri, Purcell (bib2) 2011; 3
Maass, Harrison, Grant, Shoemaker (bib27) 2007; 37
Tremblay, Mukherjee, Leysath, Debatis, Ofori, Baldwin, Boucher, Peters, Beamer, Sheoran, Bedenice, Tzipori, Shoemaker (bib8) 2013; 81
Feld, Thoren, Kintzer, Sterling, Tang, Greenberg, Williams, Krantz (bib10) 2010; 17
Tremblay, Kuo, Abeijon, Sepulveda, Oyler, Hu, Jin, Shoemaker (bib17) 2010; 56
Little, Leppla, Cora (bib24) 1988; 56
Moayeri, Tremblay, Debatis, Dmitriev, Kashentseva, Yeh, Cheung, Curiel, Leppla, Shoemaker (bib21) 2016; 23
López-Requena, Burrone, Cesco-Gaspere (bib23) 2012; 2
Hultberg, Temperton, Rosseels, Koenders, Gonzalez-Pajuelo, Schepens, Ibañez, Vanlandschoot, Schillemans, Saunders, Weiss, Saelens, Melero, Verrips, Van Gucht, de Haard (bib19) 2011; 6
Pant (10.1074/jbc.M116.749184_bib18) 2011; 6
Chen (10.1074/jbc.M116.749184_bib2) 2011; 3
Herrera (10.1074/jbc.M116.749184_bib9) 2015; 290
Feld (10.1074/jbc.M116.749184_bib10) 2010; 17
Moayeri (10.1074/jbc.M116.749184_bib21) 2016; 23
Hassanzadeh-Ghassabeh (10.1074/jbc.M116.749184_bib5) 2013; 8
Mukherjee (10.1074/jbc.M116.749184_bib7) 2012; 7
López-Requena (10.1074/jbc.M116.749184_bib23) 2012; 2
Tremblay (10.1074/jbc.M116.749184_bib8) 2013; 81
Mukherjee (10.1074/jbc.M116.749184_bib15) 2014; 9
Little (10.1074/jbc.M116.749184_bib24) 1988; 56
Pannifer (10.1074/jbc.M116.749184_bib29) 2001; 414
Leysath (10.1074/jbc.M116.749184_bib12) 2011; 79
Thullier (10.1074/jbc.M116.749184_bib11) 2013; 8
Lim (10.1074/jbc.M116.749184_bib16) 2005; 73
Moayeri (10.1074/jbc.M116.749184_bib14) 2013; 57
Kaliberov (10.1074/jbc.M116.749184_bib20) 2014; 94
Park (10.1074/jbc.M116.749184_bib25) 2000; 18
Vance (10.1074/jbc.M116.749184_bib6) 2013; 288
Chen (10.1074/jbc.M116.749184_bib28) 2009; 77
Liu (10.1074/jbc.M116.749184_bib13) 2010; 8
Pomerantsev (10.1074/jbc.M116.749184_bib26) 2006; 74
Maass (10.1074/jbc.M116.749184_bib27) 2007; 37
Moayeri (10.1074/jbc.M116.749184_bib1) 2015; 69
Adams (10.1074/jbc.M116.749184_bib22) 2016
Hultberg (10.1074/jbc.M116.749184_bib19) 2011; 6
Moayeri (10.1074/jbc.M116.749184_bib3) 2015; 290
Muyldermans (10.1074/jbc.M116.749184_bib4) 2013; 82
Tremblay (10.1074/jbc.M116.749184_bib17) 2010; 56
References_xml – volume: 3
  start-page: 1004
  year: 2011
  end-page: 1019
  ident: bib2
  article-title: Monoclonal antibody therapies against anthrax
  publication-title: Toxins
  contributor:
    fullname: Purcell
– volume: 37
  start-page: 953
  year: 2007
  end-page: 962
  ident: bib27
  article-title: Three surface antigens dominate the mucosal antibody response to gastrointestinal L3-stage strongylid nematodes in field immune sheep
  publication-title: Int. J. Parasitol
  contributor:
    fullname: Shoemaker
– volume: 79
  start-page: 4609
  year: 2011
  end-page: 4616
  ident: bib12
  article-title: Mouse monoclonal antibodies to anthrax edema factor protect against infection
  publication-title: Infect. Immun
  contributor:
    fullname: Leppla
– volume: 56
  start-page: 990
  year: 2010
  end-page: 998
  ident: bib17
  article-title: Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of
  publication-title: Toxicon
  contributor:
    fullname: Shoemaker
– volume: 81
  start-page: 4592
  year: 2013
  end-page: 4603
  ident: bib8
  article-title: A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2
  publication-title: Infect. Immun
  contributor:
    fullname: Shoemaker
– volume: 9
  start-page: e106422
  year: 2014
  ident: bib15
  article-title: Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein
  publication-title: PLoS ONE
  contributor:
    fullname: Shoemaker
– volume: 57
  start-page: 4139
  year: 2013
  end-page: 4145
  ident: bib14
  article-title: Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection
  publication-title: Antimicrob. Agents Chemother
  contributor:
    fullname: Leppla
– volume: 73
  start-page: 6547
  year: 2005
  end-page: 6551
  ident: bib16
  article-title: An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin
  publication-title: Infect. Immun
  contributor:
    fullname: Inn
– volume: 8
  start-page: 1013
  year: 2013
  end-page: 1026
  ident: bib5
  article-title: Nanobodies and their potential applications
  publication-title: Nanomedicine
  contributor:
    fullname: Muyldermans
– volume: 290
  start-page: 27880
  year: 2015
  end-page: 27889
  ident: bib9
  article-title: Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies
  publication-title: J. Biol. Chem
  contributor:
    fullname: Mantis
– volume: 77
  start-page: 3902
  year: 2009
  end-page: 3908
  ident: bib28
  article-title: Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody
  publication-title: Infect. Immun
  contributor:
    fullname: Purcell
– volume: 288
  start-page: 36538
  year: 2013
  end-page: 36547
  ident: bib6
  article-title: Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin
  publication-title: J. Biol. Chem
  contributor:
    fullname: Shoemaker
– volume: 414
  start-page: 229
  year: 2001
  end-page: 233
  ident: bib29
  article-title: Crystal structure of the anthrax lethal factor
  publication-title: Nature
  contributor:
    fullname: Liddington
– volume: 94
  start-page: 893
  year: 2014
  end-page: 905
  ident: bib20
  article-title: Adenoviral targeting using genetically incorporated camelid single variable domains
  publication-title: Lab. Invest
  contributor:
    fullname: Curiel
– volume: 6
  start-page: e17665
  year: 2011
  ident: bib19
  article-title: Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
  publication-title: PLoS ONE
  contributor:
    fullname: de Haard
– volume: 18
  start-page: 293
  year: 2000
  end-page: 302
  ident: bib25
  article-title: Optimized production and purification of
  publication-title: Protein Expr. Purif
  contributor:
    fullname: Leppla
– volume: 7
  start-page: e29941
  year: 2012
  ident: bib7
  article-title: A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
  publication-title: PLoS ONE
  contributor:
    fullname: Shoemaker
– volume: 2
  start-page: 159
  year: 2012
  ident: bib23
  article-title: Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins
  publication-title: Front. Oncol
  contributor:
    fullname: Cesco-Gaspere
– volume: 69
  start-page: 185
  year: 2015
  end-page: 208
  ident: bib1
  article-title: Anthrax pathogenesis
  publication-title: Annu. Rev. Microbiol
  contributor:
    fullname: Liu
– volume: 56
  start-page: 1807
  year: 1988
  end-page: 1813
  ident: bib24
  article-title: Production and characterization of monoclonal antibodies to the protective antigen component of
  publication-title: Infect. Immun
  contributor:
    fullname: Cora
– volume: 74
  start-page: 682
  year: 2006
  end-page: 693
  ident: bib26
  article-title: Genome engineering in
  publication-title: Infect. Immun
  contributor:
    fullname: Leppla
– volume: 23
  start-page: 213
  year: 2016
  end-page: 218
  ident: bib21
  article-title: Adenoviral expression of a bispecific VHH- based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice
  publication-title: Clin. Vaccine Immunol
  contributor:
    fullname: Shoemaker
– volume: 8
  start-page: 455
  year: 2010
  end-page: 462
  ident: bib13
  article-title: Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of
  publication-title: Cell Host Microbe
  contributor:
    fullname: Leppla
– volume: 6
  start-page: 583
  year: 2011
  end-page: 593
  ident: bib18
  article-title: Lactobacilli producing bispecific llama-derived anti-rotavirus proteins
  publication-title: Future Microbiol
  contributor:
    fullname: Hammarström
– year: 2016
  ident: bib22
  article-title: Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin fv domain: an investigation into the correlation between affinity and serum half-life
  publication-title: Mabs
  contributor:
    fullname: Heywood
– volume: 17
  start-page: 1383
  year: 2010
  end-page: 1390
  ident: bib10
  article-title: Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers
  publication-title: Nat. Struct. Mol. Biol
  contributor:
    fullname: Krantz
– volume: 8
  start-page: e65855
  year: 2013
  ident: bib11
  article-title: Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of
  publication-title: PLoS ONE
  contributor:
    fullname: Pelat
– volume: 82
  start-page: 775
  year: 2013
  end-page: 797
  ident: bib4
  article-title: Nanobodies: natural single-domain antibodies
  publication-title: Annu. Rev. Biochem
  contributor:
    fullname: Muyldermans
– volume: 290
  start-page: 6584
  year: 2015
  end-page: 6595
  ident: bib3
  article-title: A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model
  publication-title: J. Biol. Chem
  contributor:
    fullname: Shoemaker
– volume: 17
  start-page: 1383
  year: 2010
  ident: 10.1074/jbc.M116.749184_bib10
  article-title: Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers
  publication-title: Nat. Struct. Mol. Biol
  doi: 10.1038/nsmb.1923
  contributor:
    fullname: Feld
– volume: 7
  start-page: e29941
  year: 2012
  ident: 10.1074/jbc.M116.749184_bib7
  article-title: A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0029941
  contributor:
    fullname: Mukherjee
– volume: 8
  start-page: 455
  year: 2010
  ident: 10.1074/jbc.M116.749184_bib13
  article-title: Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2010.10.004
  contributor:
    fullname: Liu
– volume: 6
  start-page: e17665
  year: 2011
  ident: 10.1074/jbc.M116.749184_bib19
  article-title: Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0017665
  contributor:
    fullname: Hultberg
– volume: 2
  start-page: 159
  year: 2012
  ident: 10.1074/jbc.M116.749184_bib23
  article-title: Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins
  publication-title: Front. Oncol
  doi: 10.3389/fonc.2012.00159
  contributor:
    fullname: López-Requena
– volume: 74
  start-page: 682
  year: 2006
  ident: 10.1074/jbc.M116.749184_bib26
  article-title: Genome engineering in Bacillus anthracis using Cre recombinase
  publication-title: Infect. Immun
  doi: 10.1128/IAI.74.1.682-693.2006
  contributor:
    fullname: Pomerantsev
– volume: 79
  start-page: 4609
  year: 2011
  ident: 10.1074/jbc.M116.749184_bib12
  article-title: Mouse monoclonal antibodies to anthrax edema factor protect against infection
  publication-title: Infect. Immun
  doi: 10.1128/IAI.05314-11
  contributor:
    fullname: Leysath
– volume: 8
  start-page: e65855
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib11
  article-title: Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0065855
  contributor:
    fullname: Thullier
– volume: 73
  start-page: 6547
  year: 2005
  ident: 10.1074/jbc.M116.749184_bib16
  article-title: An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin
  publication-title: Infect. Immun
  doi: 10.1128/IAI.73.10.6547-6551.2005
  contributor:
    fullname: Lim
– volume: 9
  start-page: e106422
  year: 2014
  ident: 10.1074/jbc.M116.749184_bib15
  article-title: Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0106422
  contributor:
    fullname: Mukherjee
– year: 2016
  ident: 10.1074/jbc.M116.749184_bib22
  article-title: Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin fv domain: an investigation into the correlation between affinity and serum half-life
  publication-title: Mabs
  doi: 10.1080/19420862.2016.1185581
  contributor:
    fullname: Adams
– volume: 8
  start-page: 1013
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib5
  article-title: Nanobodies and their potential applications
  publication-title: Nanomedicine
  doi: 10.2217/nnm.13.86
  contributor:
    fullname: Hassanzadeh-Ghassabeh
– volume: 18
  start-page: 293
  year: 2000
  ident: 10.1074/jbc.M116.749184_bib25
  article-title: Optimized production and purification of Bacillus anthracis lethal factor
  publication-title: Protein Expr. Purif
  doi: 10.1006/prep.2000.1208
  contributor:
    fullname: Park
– volume: 82
  start-page: 775
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib4
  article-title: Nanobodies: natural single-domain antibodies
  publication-title: Annu. Rev. Biochem
  doi: 10.1146/annurev-biochem-063011-092449
  contributor:
    fullname: Muyldermans
– volume: 37
  start-page: 953
  year: 2007
  ident: 10.1074/jbc.M116.749184_bib27
  article-title: Three surface antigens dominate the mucosal antibody response to gastrointestinal L3-stage strongylid nematodes in field immune sheep
  publication-title: Int. J. Parasitol
  doi: 10.1016/j.ijpara.2007.02.005
  contributor:
    fullname: Maass
– volume: 290
  start-page: 27880
  year: 2015
  ident: 10.1074/jbc.M116.749184_bib9
  article-title: Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M115.658070
  contributor:
    fullname: Herrera
– volume: 288
  start-page: 36538
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib6
  article-title: Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M113.519207
  contributor:
    fullname: Vance
– volume: 56
  start-page: 990
  year: 2010
  ident: 10.1074/jbc.M116.749184_bib17
  article-title: Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2010.07.003
  contributor:
    fullname: Tremblay
– volume: 69
  start-page: 185
  year: 2015
  ident: 10.1074/jbc.M116.749184_bib1
  article-title: Anthrax pathogenesis
  publication-title: Annu. Rev. Microbiol
  doi: 10.1146/annurev-micro-091014-104523
  contributor:
    fullname: Moayeri
– volume: 6
  start-page: 583
  year: 2011
  ident: 10.1074/jbc.M116.749184_bib18
  article-title: Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
  publication-title: Future Microbiol
  doi: 10.2217/fmb.11.32
  contributor:
    fullname: Pant
– volume: 414
  start-page: 229
  year: 2001
  ident: 10.1074/jbc.M116.749184_bib29
  article-title: Crystal structure of the anthrax lethal factor
  publication-title: Nature
  doi: 10.1038/n35101998
  contributor:
    fullname: Pannifer
– volume: 94
  start-page: 893
  year: 2014
  ident: 10.1074/jbc.M116.749184_bib20
  article-title: Adenoviral targeting using genetically incorporated camelid single variable domains
  publication-title: Lab. Invest
  doi: 10.1038/labinvest.2014.82
  contributor:
    fullname: Kaliberov
– volume: 56
  start-page: 1807
  year: 1988
  ident: 10.1074/jbc.M116.749184_bib24
  article-title: Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin
  publication-title: Infect. Immun
  doi: 10.1128/iai.56.7.1807-1813.1988
  contributor:
    fullname: Little
– volume: 57
  start-page: 4139
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib14
  article-title: Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection
  publication-title: Antimicrob. Agents Chemother
  doi: 10.1128/AAC.00941-13
  contributor:
    fullname: Moayeri
– volume: 23
  start-page: 213
  year: 2016
  ident: 10.1074/jbc.M116.749184_bib21
  article-title: Adenoviral expression of a bispecific VHH- based neutralizing agent that targets protective antigen provides prophylactic protection from anthrax in mice
  publication-title: Clin. Vaccine Immunol
  doi: 10.1128/CVI.00611-15
  contributor:
    fullname: Moayeri
– volume: 290
  start-page: 6584
  year: 2015
  ident: 10.1074/jbc.M116.749184_bib3
  article-title: A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M114.627943
  contributor:
    fullname: Moayeri
– volume: 81
  start-page: 4592
  year: 2013
  ident: 10.1074/jbc.M116.749184_bib8
  article-title: A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2
  publication-title: Infect. Immun
  doi: 10.1128/IAI.01033-13
  contributor:
    fullname: Tremblay
– volume: 77
  start-page: 3902
  year: 2009
  ident: 10.1074/jbc.M116.749184_bib28
  article-title: Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody
  publication-title: Infect. Immun
  doi: 10.1128/IAI.00200-09
  contributor:
    fullname: Chen
– volume: 3
  start-page: 1004
  year: 2011
  ident: 10.1074/jbc.M116.749184_bib2
  article-title: Monoclonal antibody therapies against anthrax
  publication-title: Toxins
  doi: 10.3390/toxins3081004
  contributor:
    fullname: Chen
SSID ssj0000491
Score 2.4061246
Snippet Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic...
Infection with Bacillus anthracis , the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 21596
SubjectTerms Animals
Anthrax - drug therapy
Anthrax - immunology
Anthrax - pathology
anthrax toxin
Antibodies, Bacterial - immunology
Antibodies, Bacterial - pharmacology
Antibodies, Bispecific - immunology
Antibodies, Bispecific - pharmacology
Antibodies, Neutralizing - immunology
Antibodies, Neutralizing - pharmacology
antibody
Antigens, Bacterial - immunology
Bacillus anthracis - immunology
Bacterial Toxins - antagonists & inhibitors
Bacterial Toxins - immunology
Camelids, New World
epitope mapping
Female
Mice
microbial pathogenesis
Molecular Bases of Disease
phage display
RAW 264.7 Cells
Single-Domain Antibodies - immunology
Single-Domain Antibodies - pharmacology
toxin
VHH
VNA
Title A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection
URI https://dx.doi.org/10.1074/jbc.M116.749184
https://www.ncbi.nlm.nih.gov/pubmed/27539858
https://search.proquest.com/docview/1835535631
https://pubmed.ncbi.nlm.nih.gov/PMC5076830
Volume 291
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa6vcAFQctjeVSDhFA5ZF-24-xxWbpaHouKukW9RRPHYYO6TqUEqfw-_hhjJ15RHheusS1bmYnnc-bzfIy9SFSui1zoaJRxV1Q7lhEqk0SYcMGNIYDrS-avPsbLc_HuQl7sMRnuwnjSvs7Kgb3cDmy58dzKq60eBp7Y8HQ1ly59xEfDHutR-A1H9LD9ik4mz3EPJjIJ9XyUGH7N9GA1HscDRX0SJ8kzIbQ-TZze-9-j0p-o83fy5C_RaHGX3elgJMza5d5je8YesMOZpSP09ju8BE_s9H_MD9iteRB1O2Q_ZvDGMzEMnJkGqgLOKHZdmiivtlhamNmmzCrHLITjz8tl_QrwCz2vGyCgCF5VAa9hXV1T3w-m2dAa0OZwkpstwqLV7oHT9nZfDQivsS5rIGAMThk01Kp181Jb6a55OqoSzNwFL1hvsHGDXV6j3k0cJn3b0cbsfXa-OFnPl1Gn4xBpIXhDR9Qs4Tgu1ERnnGvMCVbkSDbUyVSqXDkBJUKCtHkQOIkLghxYTI3MpCjygt4zf8D2bWXNIwY4jaXWI4W0TwtlEKUWRYZKxyOd4cj02XGwY3rVlutIfZpdiZSsnzrrp631-2wS7Jx2aKNFESkFk38Peh48IiXLueQKWlN9q1PaGqXkMubjPnvYeshuBcHL-kzd8J1dB1fj-2YLub6v9d25-uP_HvmE3SaMF3v-oXrK9snS5hnhqCY7Yr33n5Ij__X8BObnINU
link.rule.ids 230,314,727,780,784,885,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVKOZQLghbo8jlICJVDdrNrO84ew9JVCrtVpW5Rb5HjOGxQ16mUIJXfxx9j7MQryseFa2zLVmYy8xw_zyPkTSwKVRZMBWFObVHtiAdS6DiQMWVUawS4rmT-8jRKL9jHS365Q7i_C-NI-yqvhuZqMzTV2nErrzdq5Hlio7PljNvjIxqO7pC7nIrp2G_SfQBmvVCeZR9MeOwr-gg2-pqr4XI8joYC-8RWlGeCeH0aW8X3v-elP3Hn7_TJX_LR_AG53wNJSLoFPyQ72uyTg8TgJnrzHd6Co3a6f-b7ZG_mZd0OyI8EPjguhoZz3UJdwjlmrysdFPVGVgYS01Z5bbmFcPQ5TZt3IL_g86YFhIrgdBXkDazqG-y70O0a1yBNAceF3kiYd-o9cNbd72tAwnvZVA0gNAarDeqr1dp5sa2yFz0tWQkSe8ULVmvZ2sH2ZKPZTuwnPemJY-YRuZgfr2Zp0Cs5BIox2uImNY-pHJdionJKlSwQWBQSrajiKReFsBJKiAUxfCA8iUoEHbKcap5zVhYlvmf6mOya2uhDAnIacaVCITFSM6Gl5IqVuRQqClUuQz0gR96O2XVXsCNzB-2CZWj9zFo_66w_IBNv56zHGx2OyDCd_HvQa-8RGVrOHq9Io-tvTYbBkXPKIzoekCedh2xX4L1sQMQt39l2sFW-b7eg87tq372zP_3vka_IXrpaLrLFyemnZ-QeIr7IsRHFc7KLVtcvEFW1-Uv3Df0EY1YjNQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSMAFQctjy2uQECqH7Mt2nD2GbVdb6FYrdYt6ixzHYVM1zkoJUvl9_DHGTrxqeVy4JrZsZcbjz5nP8xHyPhKZyjOmgmFKbVHtkAdS6CiQEWVUawS4rmT-4jScn7PPF_zihtSXI-2rtOibq7JvirXjVm5KNfA8scFyMeU2fUSHg02WD-6Se5yik_mDug_CrBPLswyEMY98VR_BBpep6i9Go7AvsE1khXnGiNknkVV9__ve9Cf2_J1CeWNPmj0mjzowCXE76Sfkjja7ZC82eJAuf8AHcPRO9998lzyYemm3PfIzhkPHx9BwphuocjjDHexKB1lVysJAbJoirSy_EA6-zuf1R5Df8HndAMJFcNoK8hpW1TW2PdHNGucgTQZHmS4lzFoFH1i2d_xqkPBJ1kUNCI_B6oP6irV2XHxX2MuelrAEsb3mBau1bGxnm92otwP7QY878ph5Ss5nR6vpPOjUHALFGG3woJpGVI5yMVYppUpmCC4yiZZU0YSLTFgZJcSDGEIQooQ5Ag-ZTzRPOcuzHL8zfUZ2TGX0CwJyEnKlhkJitGZCS8kVy1MpVDhUqRzqHjnwdkw2bdGOxCXbBUvQ-om1ftJav0fG3s5JhzlaLJHglvLvTu-8RyRoOZtikUZX3-sEAyTnlId01CPPWw_ZzsB7WY-IW76zbWArfd9-gwvAVfzuHH7_v3u-JfeXh7Pk5Pj0y0vyEEFf6AiJ4hXZQaPr1wismvSNW0K_AHsRJEg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Diverse+Set+of+Single-domain+Antibodies+%28VHHs%29+against+the+Anthrax+Toxin+Lethal+and+Edema+Factors+Provides+a+Basis+for+Construction+of+a+Bispecific+Agent+That+Protects+against+Anthrax+Infection&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Vrentas%2C+Catherine+E&rft.au=Moayeri%2C+Mahtab&rft.au=Keefer%2C+Andrea+B&rft.au=Greaney%2C+Allison+J&rft.date=2016-10-07&rft.eissn=1083-351X&rft.volume=291&rft.issue=41&rft.spage=21596&rft_id=info:doi/10.1074%2Fjbc.M116.749184&rft_id=info%3Apmid%2F27539858&rft.externalDocID=27539858
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon